13.08.2008
BrainsGate raises $27.5m
Medical device company BrainsGate Ltd., a subsidiary of Elron Electronic Industries (Nasdaq: ELRN; TASE: ELRN), has closed its latest financing round, raising a total of $27.5 million. Johnson & Johnson Development Corporation (JJDC), the Johnson & Johnson venture capital arm, led the round, and was joined by Agate Medical Investments LP, which invested $5 million.
Most of BrainsGate's existing investors also joined the latest round, including Elron, which invested $6.6 million, and former Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) president and CEO Israel Makov. Elron now holds 23.3% of the company. BrainsGate's other shareholders are Pitango Venture Capital, Alice Ventures, Boston Scientific Corp. (NYSE: BSX), and Israel Infinity Venture Capital. The finance was raised at a company value of $50 million before money. BrainsGate is headquartered in Caesarea and employs 50 people.
|
|
|
|
November 17, 2009
Investigational neurostimulation device aims to reduce stroke damage
Stroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24 (PhysOrg.com)
> full story
October 13, 2009
ImpACT-24 at Central DuPage Hosital
National Investigational Trial for Emergency Stroke Care At CDH: One Illinois Hospital Tests New Device That May Reverse Brain Damage Up to 24 Hours After Stroke > full story
|
Login
